This interventional study was the first to demonstrate an in vivo role for HPSE2, supporting not only the contention that congenital motor neuropathy underlies UFS's clinical phenotype, but also that HPSE2 is somehow required for functional differentiation of motor nerves. This evidence concerns the gene HPSE2 and Ochoa syndrome.